Invention Grant
- Patent Title: Yeast cells having disrupted pathway from dihydroxyacetone phosphate to glycerol
-
Application No.: US17154190Application Date: 2021-01-21
-
Publication No.: US11691817B2Publication Date: 2023-07-04
- Inventor: Catherine Asleson Dundon , Pirkko Suominen , Aristos Aristidou , Brian J. Rush , Kari Koivuranta , Benjamin Matthew Hause , Thomas William McMullin , Kevin Roberg-Perez
- Applicant: CARGILL, INCORPORATED
- Applicant Address: US MN Wayzata
- Assignee: CARGILL, INCORPORATED
- Current Assignee: CARGILL, INCORPORATED
- Current Assignee Address: US MN Wayzata
- The original application number of the division: US12281286
- Main IPC: C12N15/52
- IPC: C12N15/52 ; B65G15/12 ; C12P7/06 ; C12P7/40 ; C12P7/56 ; B65G17/12 ; E01B29/32

Abstract:
Yeast cells are genetically modified to disrupt a native metabolic pathway from dihydroxyacetone to glycerol. In certain aspects, the yeast cell is of the genera Kluyveromyces, Candida or Issatchenkia. In other aspects, the yeast cell is capable of producing at least one organic acid, such as lactate. The yeast cells produce significantly less glycerol than the wild-type strains, and usually produce greater yields of desired fermentation products. Yeast cells of the invention often grow well when cultivated, despite their curtailed glycerol production.
Public/Granted literature
- US20210155411A1 YEAST CELLS HAVING DISRUPTED PATHWAY FROM DIHYDROXYACETONE PHOSPHATE TO GLYCEROL Public/Granted day:2021-05-27
Information query
IPC分类: